Interventions to increase adherence to acne treatment
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Adherence to acne medication is poor and is a major reason why treatment plans are ineffective. Recognizing solutions to nonadherence is critical. OBJECTIVE: The purpose of this study is to describe the hurdles associated with acne nonadherence and to provide mechanisms on how to ameliorate them. METHODS: PubMed database was searched. Of the 419 search results, 29 articles were reviewed to identify hurdles to adherence and corresponding solutions. RESULTS: Hurdles to primary nonadherence where the medication is not even started, include lack of knowledge, confusion about usage, weak physician-patient relationship, fear of adverse reactions, and cost. Secondary nonadherence hurdles where the medication is started but is not taken as directed include lack of results, complex regimens, side effects, busy lifestyle, forgetfulness, inconvenience, and psychiatric comorbidity. Solutions to these hurdles include treatment simplification, technology, and dynamic education. LIMITATIONS: Adherence is affected by numerous factors, but available literature analyzing acne adherence and interventions to improve adherence to treatment is limited. CONCLUSION: There are several hurdles in adhering to acne treatment. Recognition of these hurdles and finding appropriate solutions may be as important to treatment outcomes as choosing the right medication to prescribe.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Adherence rates to oral or topical acne treatments, however, are typically poor and reasons for low adherence include complex regimens, lack of efficacy, and adverse effects [3, 4].”
The cited source says what the claim attributes to it.
In the citing paper
“Regimens with side effects, low efficacy, or high complexity (e.g., using several treatments at one time, taking multiple doses in a day) can adversely affect treatment adherence [3, 4].”
In the citing paper
“While there are many treatment options available, acne is a chronic disease that requires long-term treatment [2, 4].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kirk, J., MacDonald, A., Lavender, P., Dean, J., & Rubin, G. (2017) · Biomedicine Hub · doi:10.1159/000480347 · Cited by 3,887
Adherence and health care costs
McGuire, M., & Iuga (2014) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s19801 · Cited by 708
Tuchayi, S. M., Makrantonaki, E., Ganceviciene, R., Dessinioti, C., Feldman, S. R., & Zouboulis, C. C. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.29 · Cited by 432
Self-citationRecent findings in the epidemiologic evidence, classification, and subtypes of acne vulgaris
White, G. M. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70442-6 · Cited by 334 · cited 1×
“Discussion Considering the huge burden of acne and low rates of adherence associated with acne medication, more attention to increasing adherence is needed.(11,12) A variety of hurdles to adherence exist, stemming from both inside and outside the doctor’s office.”
Adherence and health care costs
Iuga, A. O., Mcguire, M. J., Bloomberg, J. H., Maura, C., & Mcguire, J. (2016) · Cited by 331
Association of Dissatisfaction With Care and Psychiatric Morbidity With Poor Treatment Compliance
Renzi, C., Picardi, A., Abeni, D., Agostini, E., Baliva, G., Pasquini, P., Puddu, P., & Braga, M. (2002) · Archives of Dermatology · doi:10.1001/archderm.138.3.337 · Cited by 249 · cited 1×
“22 Simplification serves as one solution to nonadherence, as it allows treatment to better fit into a patient’s lifestyle.”
Large‐scale worldwide observational study of adherence with acne therapy
Dréno, B., Thiboutot, D., Gollnick, H., Finlay, A. Y., Layton, A., Leyden, J. J., Leutenegger, E., Perez, M., & on behalf of the Global Alliance to Improve Outcomes in Acne (2010) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2010.04416.x · Cited by 195 · cited 1×
“Discussion Considering the huge burden of acne and low rates of adherence associated with acne medication, more attention to increasing adherence is needed.(11,12) A variety of hurdles to adherence exist, stemming from both inside and outside the doctor’s office.”
Adherence to topical therapy increases around the time of office visits
Feldman, S. R., Camacho, F. T., Krejci-Manwaring, J., Carroll, C. L., & Balkrishnan, R. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.04.005 · Cited by 180 · cited 1×
“Acne medication adherence decreases over time; however, around the time of follow-up visits, medication adherence increases.(23,24,27) Scheduling follow-up visits is a potent intervention to increase adherence.”
Self-citationFrom new findings in acne pathogenesis to new approaches in treatment
Gollnick, H. P. M. (2015) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13186 · Cited by 174 · cited 2×
“15 However, combination treatments have overcome all adherence obstacles, especially in maintaining good adherence over time.”
Topical drug delivery systems in dermatology: a review of patient adherence issues
Tan, X., Feldman, S. R., Chang, J., & Balkrishnan, R. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.711756 · Cited by 159 · cited 3×
“13,15 Topical and oral antibiotics used as monotherapy can lead to antibiotic resistance.”
Self-citation
Cited by
Thiboutot, D. M., Dréno, B., Abanmi, A., Alexis, A. F., Araviiskaia, E., Barona Cabal, M. I., Bettoli, V., Casintahan, F., Chow, S., da Costa, A., et al. (2018) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2017.09.078 · Cited by 418
“A simple regimen is also beneficial for patient adherence.(39,40) Although there is a solid rationale and strong recommendations for use of topical retinoids in both the EDF and AAD guidelines,(3,14) a study of prescribing practices during 2012-2014 reported that dermatologists prescribed retinoids for just 58.”
BackgroundAcne vulgaris: A review of the pathophysiology, treatment, and recent nanotechnology based advances
Vasam, M., Korutla, S., & Bohara, R. A. (2023) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2023.101578 · Cited by 231
Current Issues in the Treatment of Acne Vulgaris
Habeshian, K. A., & Cohen, B. A. (2020) · Pediatrics · doi:10.1542/peds.2019-2056l · Cited by 179
“Despite the negative impacts of acne vulgaris, treatment compliance is poor because of numerous factors.(6) Adolescents discontinue treatment, in part, because of early improvement, perception of worsening acne, and side effects, especially with topical treatments,(7) suggesting that anticipatory guidance and mitigati…”
BackgroundTopical Retinoids in Acne Vulgaris: A Systematic Review
Kolli, S. S., Pecone, D., Pona, A., Cline, A. E., & Feldman, S. R. (2019) · American Journal of Clinical Dermatology · doi:10.1007/s40257-019-00423-z · Cited by 163
Self-citationAcne treatment review and future perspectives
Mohsin, N., Hernandez, L. E. D. L. C., Martin, M. R., Does, A. V., & Nouri, K. (2022) · Dermatologic Therapy · doi:10.1111/dth.15719 · Cited by 92
“ance, as adherence to current treatments is often impeded by the side effects of skin irritation, photosensitivity, antibiotic resistance, and regimen complexity.(70) Topical formulations that incorporate more”
BackgroundThe Anti-Inflammatory Effects of Cannabidiol (CBD) on Acne
Peyravian, N., Deo, S. K., Daunert, S., & Jimenez, J. J. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s355489 · Cited by 85
“Although generally regarded as safe, Isotretinoin is also known to exhibit embryotoxic and teratogenic properties.(5,19) These potential adverse side effects may deter patients from commencing or continuing their acne treatment, therefore highlighting the need for new, natural, and safe therapies.”
BackgroundStein Gold, L., Baldwin, H., Kircik, L. H., Weiss, J. S., Pariser, D. M., Callender, V., Lain, E., Gold, M., Beer, K., Draelos, Z., et al. (2022) · American Journal of Clinical Dermatology · doi:10.1007/s40257-021-00650-3 · Cited by 51
Ip, A., Müller, I., Geraghty, A. W. A., McNiven, A., Little, P. S., & Santer, M. (2019) · British Journal of Dermatology · doi:10.1111/bjd.18684 · Cited by 49
Gold, L. S., Lain, E. L., Rosso, J. Q. D., Gold, M. H., Draelos, Z. D., Eichenfield, L. F., Sadick, N. S., Werschler, W. P., Gooderham, M., & Lupo, M. P. (2023) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2022.08.069 · Cited by 33
Treatment Advances for Acne Vulgaris: The Scientific Role of Cannabinoids
Ferreira, I., Lopes, C. M., & Amaral, M. H. (2024) · Cosmetics · doi:10.3390/cosmetics11010022 · Cited by 28
“Another set of side effects may include dry eyes, lips, and nose, dermatitis, and the expression of embryotoxic and teratogenic properties [71,89–91].”
BackgroundTan, J. K. L., Alexis, A. F., Baldwin, H. E., Beissert, S., Bettoli, V., Rosso, J. Q. D., Dréno, B., Gold, L. S., Harper, J. C., Lynde, C. W., et al. (2021) · JAAD International · doi:10.1016/j.jdin.2021.06.007 · Cited by 27
Talianu, M.-T., Dinu‐Pîrvu, C., Ghica, M. V., Anuța, V., Jinga, V., & Popa, L. (2020) · Nanomaterials · doi:10.3390/nano10112292 · Cited by 20
“An improvement along this path consists in the development of some commercial products with combinations of APIs in low concentrations that can assure a better compliance [102].”
BackgroundAraviiskaia, E., Layton, A., Estebaranz, J. L. L., Ochsendorf, F. R., & Micali, G. (2022) · Dermatology Research and Practice · doi:10.1155/2022/3644720 · Cited by 31
Topically Applied Therapies for the Treatment of Skin Disease: Past, Present, and Future
Brown, M. B., Williams, A., Chilcott, R. P., Brady, B., Lenn, J. D., Evans, C., Allen, L., McAuley, W. J., Beebeejaun, M., Haslinger, J., et al. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.123.000549 · Cited by 26
Degitz, K., & Ochsendorf, F. R. (2017) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.13278 · Cited by 41
Salamzadeh, J., Kachousangi, S. T., Hamzelou, S., Naderi, S., & Daneshvar, E. (2020) · Dermatologic Therapy · doi:10.1111/dth.14408 · Cited by 22
“528 Duration of disease (months) 36 (12-81) 36 (24-75) .”
Calprotectin in acne vulgaris: A possible contributory role
Fouda, I., Obaid, Z. M., Hegazy, S., al-samee, H. A., & Nofal, A. (2020) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.13574 · Cited by 14
Drug-Induced Acne in Inflammatory Bowel Disease: A Practical Guide for the Gastroenterologist
Temido, M. J., Honap, S., Bursztejn, A. C., Portela, F., Jairath, V., Danese, S., Spencer, A., & Peyrin‐Biroulet, L. (2024) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003119 · Cited by 16
“Explaining the consultation points highlighted in Table 4 and discussing commonly occurring side e ff ects of topical therapy can promote adherence (78).”
Pyrrolidine Dithiocarbamate Suppresses Cutibacterium acnes-Induced Skin Inflammation
Shin, J. H., Kim, S. S., & Seo, S. R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054444 · Cited by 14
Developments and challenges in dermatology: an update from the Interactive Derma Academy (IDeA) 2019
Luger, T. A., Dirschka, T., Eyerich, K., Gollnick, H. P. M., Gupta, G., Lambert, J., Micali, G., Ochsendorf, F. R., Ständer, S., & Traidl‐Hoffmann, C. (2020) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.17009 · Cited by 11
Wijayadi, L. J., & Rusli, T. R. (2020) · IOP Conference Series Materials Science and Engineering · doi:10.1088/1757-899x/852/1/012016 · Cited by 11
“However, these anti-acne drugs have their individual side effects.(8) This motivates us to find an alternative treatment derived from natural ingredients that have minimal side effects.”
BackgroundTuran, S., Turan, I. K., & Özbağçıvan, Ö. (2020) · The Turkish Journal of Pediatrics · doi:10.24953/turkjped.2020.06.013 · Cited by 13
Acne in primary care: A cross-sectional analysis
Brown, H., Tapley, A., van Driel, M., Davey, A., Holliday, E. G., Ball, J., Morgan, S., Patsan, I., Mulquiney, K. L., Spike, N., et al. (2019) · Australian Journal of General Practice · doi:10.31128/ajgp-02-19-4864 · Cited by 11
Alghofaili, A., Alolayan, S. A., Alhowail, A. H., Mobark, M. A., Alderaibi, S., & Almogbel, Y. S. (2021) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s335007 · Cited by 12
Eichenfield, L. F., Gold, L. S., Kircik, L., Werschler, W. P., Beer, K. R., Draelos, Z. D., Tanghetti, E. A., Papp, K. A., Baldwin, H. E., Lain, E. L., et al. (2023) · Pediatric Dermatology · doi:10.1111/pde.15283 · Cited by 12
“This is important as treatment regimens requiring many weeks or months to show improvement may lead patients to believe they are not efficacious and discontinue treatment.(9) F IGURE 2 Inflammatory and noninflammatory lesion reductions by study visit (intent-to-treat population).”
BackgroundPera, V., Vaerenbergh, F. V., Kors, J. A., van Mulligen, E. M., Parry, R., de Wilde, M., Lahousse, L., van der Lei, J., Rijnbeek, P. R., & Verhamme, K. M. C. (2023) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5743 · Cited by 9
“49,50 Narratives of received ICSRs, provided by the FDA, show how patients have over-dosed on over-the-counter (OTC) adapalene, without providing further background information on what was the root-cause of overdosing.”
BackgroundBettoli, V., Coutanceau, C., & Georgescu, V. (2019) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s205170 · Cited by 9
“However, they can occasionally be severe or even intolerable, causing a great deal of discomfort to the patient and severely hampering already low levels of compliance with therapy.(19,20) These low levels of compliance compromise treatment efficacy and have an impact on clinical outcomes.”
BackgroundKircik, L., Gold, L. S., Gold, M., Weiss, J., Harper, J. C., Rosso, J. Q. D., Bunick, C. G., Bhatia, N. D., Tanghetti, E. A., Eichenfield, L. F., et al. (2024) · Dermatology and Therapy · doi:10.1007/s13555-024-01155-7 · Cited by 14
“Furthermore, combination treatments that are delivered in a fixed-dose formulation may improve patient adherence, and thereby treat-ment success, by reducing treatment complexity [5].”
BackgroundSitohang, I. B. S., Norawati, L., Yenny, S. W., Kusumawardani, A., Murlistyarini, S., Setiawan, S. V., Kekalih, A., Riany, G., & Kérob, D. (2024) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s474331 · Cited by 8
Woźna, J., Bałoniak, A., Stępka, J., Polańska, A., Mojs, E. H., & Żaba, R. W. (2025) · Biomedicines · doi:10.3390/biomedicines13081847 · Cited by 7
Prescription-level factors associated with primary nonadherence to dermatologic medications
Rutherford, A., Glass, D. A., Suarez, E. A., & Adamson, A. S. (2017) · Journal of Dermatological Treatment · doi:10.1080/09546634.2017.1365115 · Cited by 7
“Other potential driving factors for nonadherence, particularly for oral antifungals, could be patient fear regarding oral antifungal side effect profile (2).”
BackgroundKumar, S., Sharma, P. K., Malviya, R., Alam, A., & Sagar, S. R. (2023) · Anti-Infective Agents · doi:10.2174/2211352521666230911155555 · Cited by 7
Degitz, K., & Ochsendorf, F. R. (2017) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.30_13278 · Cited by 5
Use of Dermocosmetics in Acne Management: A Middle East‐North Africa Consensus
Zimmo, S., Zaher, H. A. E.-M., Said, A., Elmorsy, E. H., Litaiem, N., Hammadi, A. A., Sayed, A. E., & Steinhoff, M. S. (2025) · International Journal of Dermatology · doi:10.1111/ijd.70070 · Cited by 5
“Despite the associated quality of life impairments and potential for long-term scarring and/or PIH, studies have consistently shown poor adherence to acne medications [40, 41].”
Brammann, C., Bornemann, C., Kannewurf, R., & Müller-Goymann, C. C. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101990 · Cited by 4
The Role of Herbal Plant Essential Oils in the Treatment of Acne Vulgaris
Kelvin, & Wijayadi, L. J. (2022) · Science Midwifery · doi:10.35335/midwifery.v10i4.764 · Cited by 7
“Pharmacological treatment of AV has been widely used. studied, but there are still many factors that reduce its effectiveness such as lack of patient compliance, lack of knowledge about how to use drugs, fear of side effects that can occur, and the number of costs incurred (Tuchayi et al., 2016).”
BackgroundUpdates on Topical Dyad and Triple Combination Therapies Approved for Acne Vulgaris
Podwójniak, A., Tan, I. J., Sauer, J., Parikh, A. K., COHEN, B. A., & Heath, C. R. (2024) · Cureus · doi:10.7759/cureus.61413 · Cited by 7
Hakak, H., Neimann, K., Toledano, O., & Erlich, M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32275 · Cited by 3
Aleid, A. M., Aleid, A. M., Nukaly, H. Y., Mustanyir, H. A. A., Almasabi, G. Y., Alsaeed, A. M., Nadra, R. W., Alshammari, B., Alsaqri, S., Alsaleh, K., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-05543-7 · Cited by 5
“However, the success of treatment is dependent upon the patient’s adherence and side effects 3,4 .”
Kouotou, E. A., Madjoukeng, A. S. N., Feungue, U. N., Tounouga, D. N., Nkoro, G. A., Sigha, O. B., Kotto, R. E., & Bissek, A. C. Z.-K. (2022) · Our Dermatology Online · doi:10.7241/ourd.20224.5 · Cited by 3
Comparative Evaluation of Topical Antibiotics in Treatment of Mild to Moderate Acne Vulgaris
AL-mosawi, R. O., Hassan, J. K., & AL-tameemi, F. F. (2022) · International Journal of Drug Delivery Technology · doi:10.25258/ijddt.12.4.74 · Cited by 3
Kwiatkowska, D., Wolańska-Buzalska, D., Łanocha, M., Zegarska, B., Bergler-Czop, B. S., & Reich, A. (2023) · Forum Dermatologicum · doi:10.5603/fd.97344 · Cited by 6
Koç, H. A., Güney, C. A., & Önal, B. S. (2025) · Dermatology Practical & Conceptual · doi:10.5826/dpc.1501a4854 · Cited by 3
“In studies evaluating patients with AV, the factors that reduce treatment adherence include lack of information, difficulties in using medications, poor doctor-patient relationships, side effects, cost, and psychiatric comorbidities [22,23].”
Aleissa, S., Baabdullah, A. M., Zimmo, B. S., Abduljabbar, M., Hariri, J., Alghamdi, Y. K., Almutairi, S. N., & Alsifri, S. (2026) · Dermato · doi:10.3390/dermato6010002 · Cited by 2
Davis, S., Tan, X., Snyder, S. N., Crandell, I., Al‐Dabagh, A., Lin, H., Balkrishnan, R., Chang, J., & Feldman, S. R. (2016) · Springer eBooks · doi:10.1007/978-3-319-30994-1_9 · Cited by 2
Self-citationDraelos, Z. D., Kircik, L., Zeichner, J., Pillai, R., Angel, A., Guenin, E., & Tanghetti, E. A. (2024) · Dermatologic Therapy · doi:10.1155/2024/5575030 · Cited by 2
“However, their clinical efectiveness can be limited by tolerability concerns and poor adherence to treatment [1, 6, 7].”
BackgroundHavet, A., Moskal, A., Payet, C., Massardier, J., Lebrun‐Vignes, B., Jonville‐Béra, A. ‐., Chanelière, M., & Viprey, M. (2025) · Dermatology and Therapy · doi:10.1007/s13555-025-01409-y · Cited by 2
Strategies to Improve Adherence
Kolli, S. S., Pona, A., Cline, A. E., & Feldman, S. R. (2019) · Updates in clinical dermatology · doi:10.1007/978-3-030-27809-0_3 · Cited by 2
Self-citationBasha, M. A., Abdelmageed, R. G., & Bayomy, N. R. (2021) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2021.184214 · Cited by 2
“Moreover, hypersensitivity to androgen production and inflammatory cytokines affected by the innate immune system adds to the complexity of the underlying disease pathogenesis ((11)).”
BackgroundHaidari, W., Glines, K. R., Cline, A. E., & Feldman, S. R. (2019) · Updates in clinical dermatology · doi:10.1007/978-3-030-27809-0_9 · Cited by 2
Self-citationCalprotectin may be positively associated with the severity of acne vulgaris
Al-tameemi, S., Abid, Z., Chen, W., Alshammri, F., & Abid, H. A. (2022) · Baghdad Journal of Biochemistry and Applied Biological Sciences · doi:10.47419/bjbabs.v3i02.124 · Cited by 2
Perceptions of Acne and Its Treatments Among Chinese College Students: A Cross-Sectional Survey
Liu, L., Li, Y., Gu, S.-M., Wu, W., Fang, M., & Zhou, H. (2020) · International Journal of Dermatology and Venereology · doi:10.1097/jd9.0000000000000131 · Cited by 1
“According to our results, it is necessary for physicians to take the time to adequately explain acne treatment to patients.(8) Physicians’ explanations and medication guidance has been shown to help patients feel less disheartened with the lack of instant results(11) and improve adherence to acne treatment.”
BackgroundSaki, N., Mohammadi, F., Parvizi, M. M., & Kamali, M. (2025) · Dermatologic Therapy · doi:10.1155/dth/6610699 · Cited by 2
“Treatment is undertaken via suppressing sebum secretion, reducing hyperkeratinization of the pilosebaceous follicles, and alleviation of Propionibacterium infection [6, 7].”
Adherence of patients to acne therapy using systemic isotretinoin
Perlamutrov, Y. N., & Olkhovskaya, K. B. (2025) · Russian Journal of Clinical Dermatology and Venereology · doi:10.17116/klinderma202524041483 · Cited by 1
Draelos, Z. D., Baldwin, H. E., Harper, J. C., Ghannoum, M. A., Gold, L. S., Tanghetti, E. A., Wroblewski, K., & Kircik, L. (2026) · Journal of Dermatological Treatment · doi:10.1080/09546634.2026.2612873 · Cited by 1
Ferhatosmanoğlu, A., Arıca, İ. E., Polat, M., Yıldırım, M., Kalkan, G., Şahin, R. B., Tosun, M., Meral, E. N., Yıldırım, E. A., Kara, Y. A., et al. (2026) · Journal of Dermatological Treatment · doi:10.1080/09546634.2026.2620230 · Cited by 2
Nakra, G., Modi, A., Hegde, S., Bala, S., Bhushan, S., Dhoot, D. S., Balasubramanian, A., Bhosale, P., Gadkari, R., & Patil, S. (2026) · Cureus · doi:10.7759/cureus.108616 · Cited by 1
“However, despite being widely recommended, the separate application of these products may not always ensure consistent adherence, leading to suboptimal skin barrier repair and prolonged discomfort [11].”
Efficacy of Topical Tretinoin and Topical Minoxidil Cotherapy in Androgenetic Alopecia: A Review
Maas, D., Spindler, A. J., Zappi, I., Maas, K., Brody, A., Tucci, C., Garza-García, L. M., Patrocínio, J., Shapiro, J., & Sicco, K. I. L. (2026) · Skin Appendage Disorders · doi:10.1159/000553018 · Cited by 1
“Lack of efficacy, complex regimens, and side effects have been cited as the most common hurdles to adherence for both long-term topical retinoid and minoxidil therapies [61–63].”
Jha, P. K., Singh, S. K., & Rai, T. (2022) · Nepalese Medical Journal · doi:10.3126/nmj.v5i2.47237 · Cited by 1
Photopneumatic Technology for the Treatment of Mild-to-moderate Acne Vulgaris-Expert Perspectives.
Bhatia, A. C., Burgess, C., Munavalli, G. S., & Smith, J. (2023) · PubMed Central · Cited by 1
How can physicians improve medication adherence and outcomes in dermatological conditions?
Duong, J. Q., Bloomquist, R. F., & Feldman, S. R. (2024) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2024.2370911 · Cited by 1
“Physical demonstrations of topical application can reinforce patient understanding and promote proper use and improved adherence; patients who received a physical demonstration of a topical medication for acne had an overall 15% increase in adherence compared to controls [51].”
Self-citationComparison of Efficacy of Dapsone 5% Gel Vs Clindamycin 1% Gel in Mild to Moderate Acne Vulgaris
Iqra, S., Ghafoor, R., Ali, A., Qadir, M. Z., & Khurram, M. (2025) · Indus journal of bioscience research. · doi:10.70749/ijbr.v3i1.458 · Cited by 1
Widiawaty, A., Zahtamal, Z., Sandora, N., Amelinda, A., Suryo, M. A., & Priastiwi, S. (2019) · Jurnal Ilmu Kedokteran (Journal of Medical Science) · doi:10.26891/jik.v12i1.2018.25-31
SMS support group in the management of acne: A useful tool to increase adherence to treatment
Ruggiero, A., Marasca, C., Ocampo‐Garza, S. S., Fabbrocini, G., & Villani, A. (2020) · Dermatologic Therapy · doi:10.1111/dth.14663
“Acne medication adherence decreases over time; however, around the time of follow-up visits, medication adherence increases.(7) Hence, support groups may represent a useful tool in the earlier phases of acne's therapy in order to educate patients better managing their disease.”
BackgroundHalat, D. H., Basset, W. E., Mourad, N., Younes, S., & Rahal, M. K. (2021) · Archives of Pharmacy Practice · doi:10.51847/csv6noqenp
Verbesserung der Lebensqualität als zentrales Therapieziel
Reinholz, M. (2022) · Deutsche Dermatologie · doi:10.1007/s15011-022-4993-z
Anggraeni, R., Widjayanti, N., Kariosentono, H., Julianto, I., Ellistasari, E. Y., Irawanto, M. E., & Mawardi, P. (2020) · MEDICINUS · doi:10.56951/medicinus.v33i3.73
Diina, T. R., Wahyuni, I. S., & Levita, J. (2022) · Jurnal Sains Farmasi & Klinis · doi:10.25077/jsfk.9.2.71-79.2022
Current topical treatments for acne
Владиславовна, М. Е., Vladimirova, E. V., & Matushevskaya, Y. I. (2022) · Russian Journal of Clinical Dermatology and Venereology · doi:10.17116/klinderma202221051589
Treatment Modalities in Acne Scar
Salem, R. M., Rezk, S. M., & Abdelkader, S. (2023) · Benha Journal of Applied Sciences · doi:10.21608/bjas.2023.248683.1281
“Table(2) Different treatment options for acne vulgaris [15-17] :”
BackgroundGold, M. H., Lain, E., Harper, J. C., Baldwin, H. E., Guenin, E., & Gold, L. S. (2025) · Dermatology and Therapy · doi:10.1007/s13555-025-01440-z · Cited by 1
“Given the chronicity of acne vulgaris and the consequent long-term treatment time course, patient adherence presents a formidable barrier to disease management [5, 8, 9].”
Оценка уровня комплаентности у пациентов с акне и розацеа
Шакирова, А. Т. (2025) · Scientific and practical journal Healthcare of Kyrgyzstan · doi:10.51350/zdravkg2025.4.12.7.59.64
Global Trends and Hotspot Analysis of Nanomaterials in the Field of Acne: A Bibliometric Perspective
Chen, R., Tang, Y., Duan, L., Jiang, Z., & Zhu, M. (2026) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s586477 · Cited by 3
“7 With the continuous advancement of nanomedicine, nanomaterial-based drug delivery systems have demonstrated considerable potential in acne treatment.”
Cogliandro, A., Gratteri, M., Dianzani, C., Marangi, G. F., Bernardis, R. D., Angelis, G. D., Romano, R., Conforti, C., Gratteri, F., & Persichetti, P. (2026) · Aesthetic Plastic Surgery · doi:10.1007/s00266-026-05892-2
“This type of approach also may improve patient compliance, contributing to greater adherence and continuation of the proposed treatment [29].”
Santer, M., Becque, T., Essery, R., Hooper, J., Feuvre, R. L., Sach, T., Henaghan‐Sykes, K., Soulsby, I., Steele, M., Slodkowska‐Barabasz, J., et al. (2026) · NIHR Open Research · doi:10.3310/nihropenres.14302.1
Psychological Factors to Consider in Treating Patients with Acne Vulgaris
Woźna, J., Pazdrowski, P., Welc, N. A., Płócienniczak, A., Korecka, K., Żaba, R. W., Grzybowski, A. E., & Mojs, E. H. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15166347 · Cited by 2
Bansal, N., & Ahuja, R. (2026) · Cureus · doi:10.7759/cureus.117365
Becque, T., Maund, E., Essery, R., Barbieri, J. S., Stuart, B. L., Sach, T., Saxionis, I., Miah, F., Price, W., Pang, J. T., et al. (2026) · Skin Health and Disease · doi:10.1093/skinhd/vzag153
Metadata
- Authors
- Moradi Tuchayi, S., Alexander, T., Nadkarni, A., & Feldman, S. R.
- Affiliations
- Howard University (US)
- Wake Forest University Health Sciences (US)
- ORCID
- Feldman, Steven R
- Venue
- Patient Preference and Adherence
- Publisher
- Informa UK Limited
- Published
- 2016-10
- Volume
- Volume 10
- Pages
- 2091-2096
- ISSN
- 1177-889X (ISSN-L)
- PMC
- PMC5067002
- OpenAlex
- W2530658432
- Cited by
- 78
- References
- 31
- Citations by year
- 2026: 11 · 2025: 10 · 2024: 9 · 2023: 9 · 2022: 11 · 2021: 5 · 2020: 11 · 2019: 7 · 2017: 4 · 2016: 1
- FWCI
- 4.88
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Patient Preference and Adherence (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Funders
- Galderma
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Dermatology › Acne and Rosacea Treatments and Effects
- Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
- Keywords
- acne, medication adherence, treatment non-adherence, barriers to adherence, adherence interventions, physician-patient relationship, treatment simplification, patient education, drug costs, adverse effects, psychiatric comorbidity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.